Business Context and Reporting Period
Company: Safety Shot, Inc. (Note: Request metadata listed "BONK, INC." but the filing text identifies the registrant as Safety Shot, Inc.)
Filing Type: Form 8-K (Current Report)
Reporting Date: September 20, 2024 (Earliest event reported)
Business Focus: Following a strategic separation, the Company will focus exclusively on the commercialization of the Safety Shot Dietary Supplement.
Key Financial Metrics and Transactions
This filing reports specific transactional events rather than periodic financial performance metrics (e.g., revenue, profit, or cash flow). The filing text does not provide a clear value for general financial performance.
- Capital Raise (PIPE): Issued 448,029 shares to an accredited investor for gross proceeds of $500,000 at $1.12 per share (10% discount to closing price).
- Equity Compensation: Agreed to issue 1,250,000 restricted shares to Core4 Capital Corp. for consulting services over a six-month term.
- Asset Disposition: Transferred 100% of the "CB Business" (wellness consumer products) and related assets/liabilities to Caring Brands, Inc. (CB Nevada) in exchange for 3,000,000 shares of CB Nevada common stock.
Material Changes Versus Prior Period
The Company executed a significant structural change by divesting its wellness consumer products segment (CB Business). The Company states it had previously discontinued these operations and written off the assets, and therefore does not believe the disposition qualifies as a significant transaction. Post-transaction, the Company's operations are consolidated around the Safety Shot Dietary Supplement.
Guidance, Outlook, Risks, and Unusual Items
- Outlook: Management intends to focus efforts solely on the Safety Shot Dietary Supplement following the separation.
- Related Party Transactions: The Consulting Agreement involves Core4 Capital Corp., in which the Company's President, Jordan Schur, owns 15%. Other shareholders of the Consultant are members of Mr. Schur's immediate family.
- Unregistered Sales: The PIPE shares and Consultant shares were issued without registration under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D.
- Emerging Growth Company: The registrant is classified as an emerging growth company.
Investor Verification Checklist
- Verify the valuation and vesting schedule of the 1,250,000 shares issued to Core4 Capital Corp. given the related-party relationship with President Jordan Schur.
- Confirm the financial status and viability of the remaining "Safety Shot Dietary Supplement" business segment post-separation.
- Review the full text of the Separation and Exchange Agreement (Exhibit 10.3) to understand any retained liabilities or contingent obligations from the CB Business.
- Assess the impact of the 10% discount on the PIPE transaction on existing shareholder dilution.